Dergiler / Medicine Science / 2017 / Cilt: 6 - Sayı: 1

The effect of licorice drink on cytochrome P3A6 and P-glycoprotein gene transcription in rabbits

Sayfa
35–40
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

It is concluded that licorice can affect the metabolism of drugs that are CYP3A6 substrates, but it might not affect the transport of drugs dependent on P-gp

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Licorice is a widely used herb, and its components interact with a number of drugs.
📊
Temel Bulgular & Veri:The purpose of this research is to study the effect of licorice drink on the levels of cytochrome P3A6 (CYP3A6) and P-glycoprotein (P-gp) gene transcripts using rabbit as an animal model.
💡
Sonuç & Katkı:It is concluded that licorice can affect the metabolism of drugs that are CYP3A6 substrates, but it might not affect the transport of drugs dependent on P-gp
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Licorice is a widely used herb, and its components interact with a number of drugs. Rifampicin is an antibiotic known to induce some drug metabolizing enzymes and transporters and used in our study as a reference drug. The purpose of this research is to study the effect of licorice drink on the levels of cytochrome P3A6 (CYP3A6) and P-glycoprotein (P-gp) gene transcripts using rabbit as an animal model. Four groups of locally inbred male New Zealand rabbits were used, including two control groups, and two treated groups. One group was given a daily oral dose of licorice drink (4 ml/kg body weight) for one week, while the other group was given a daily oral dose of rifampicin (100 mg/kg body weight) for four days. Messenger RNAs were extracted from hepatic and the proximal (first 10-15 cm) intestinal tissues of the four groups and real-time polymerase chain reaction was conducted on them. The licorice treated group showed a significant induction of hepatic CYP3A6 expression (17.6-fold, p=0.004), and inhibition of intestinal CYP3A6 expression (7.6-fold, p=0.0006). Licorice administration did not affect P-gp expression neither in hepatic nor in intestinal tissues. Rifampicin administration significantly induced hepatic CYP3A6 expression with no significant changes in transcription of intestinal CYP3A6, hepatic and intestinal P-gp. It is concluded that licorice can affect the metabolism of drugs that are CYP3A6 substrates, but it might not affect the transport of drugs dependent on P-gp

🔖

Bu Makaleye Atıf Yap

AL-BALAWNİH, S. R. A. .. (2017). The effect of licorice drink on cytochrome P3A6 and P-glycoprotein gene transcription in rabbits. Medicine Science, Cilt: 6 - Sayı: 1, 35–40. https://ajindex.com/articles/277478

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Thummel KE, Wilkinson GR. In vitro and in vivo drug interactions involving human CYP3A4. Annu Rev Pharmacol Toxicol. 1998;38:389-430
  2. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther. 1994;270(1):414-23
  3. Paine MF, Hart HL, Ludington SS, Haining RL, Rettie AE, Zeldin DC. The human intestinal cytochrome P450 "pie". Drug Metab Dispos. 2006;34(5):880-6
  4. Kolars JC, Schmiedlin-Ren P, Schuetz JD, Fang C, Watkins PB. Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest. 1992;90(5):1871-8
  5. Tsunoda SM, Velez RL, von Moltke LL, Greenblatt DJ. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole. Clin Pharmacol Ther. 1999;66(5):461-71
  6. Lown KS, Kolars JC, Thummel KE, Barnett JL, Kunze KL, Wrighton SA, Watkins PB. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test. Drug Metab Dispos. 1994;22:947-55
  7. Damkier P, Hansen LL, Brøsen K. Effect of fluvoxamine on the pharmacokinetics of quinidine. Euro J Clin Pharmacol. 1999;55(6):451-6
  8. Hirota N, Ito K, Iwatsubo T, Green CE, Tyson CA, Shimada N, Suzuki H, Sugiyama Y. In vitro/in vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans. Biopharm Drug Dispos. 2001;22(2):53-71
  9. Watkins PB. The barrier function of CYP3A4 and P-glycoprotein in the small bowel. Adv Drug Deliv Rev. 1997;27(2-3):161-70
  10. Thörn M, Finnström N, Lundgren S, Rane A, Lööf L. Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract. Br J Clin Pharmacol. 2005;60(1):54-60
  11. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev. 2003;55(1):3-29
  12. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA. 1987;84(21):7735-8
  13. Fischer V, Einolf HJ, Cohen D. Efflux transporters and their clinical relevance. Mini Rev Med Chem. 2005;5(2):183-95
  14. Wessler JD, Grip LT, Mendell J, Giugliano RP. The P glycoprotein transport system and cardiovascul